CHU de Nice
Nice, Alpes Maritimes, France
Location status: Recruiting
NCT Number: NCT07508631
"Friedreich ataxia is the most common inherited autosomal recessive ataxia. It is caused by a GAA repeat expansion in the frataxin gene on chromosome 9q21.11. Symptoms usually begin in childhood, typically between 9 and 13 years of age. The disease leads to progressive damage of the nervous system and the heart, as well as multisystem involvement of various degrees, leading to diabetes, vision and hearing loss and scoliosis. Over time, most patients lose the ability to walk and require a wheelchair, often by their mid-twenties. The severity and progression of the disease can vary depending on various factors such as the age at onset and the size of the GAA triplet expansion.
Traditionally, Friedreich ataxia has been considered a disorder primarily affecting nerve cells, also called neuronopathy. However, recent studies using ultrasound imaging of peripheral nerves have shown that some nerves may appear enlarged, particularly in the upper limbs. This is in contrast with findings usually observed in other neuronopathies, where peripheral nerves tend to become thinner.
The aim of this study is to use nerve ultrasound to better understand changes in intraneural vascularization and nerve in patients with Friedreich ataxia. In particular, we assess the presence of intraneural blood flow within the nerves using a high-resolution ultrasound technique.
The study includes 13 patients with genetically confirmed Friedreich ataxia who are followed at the Neurogenetics Competence Center of Nice University Hospital. Ultrasound examinations are performed on the median and ulnar nerves at standardized locations: for median nerve at wrist, forearm (10 cm from the distal wrist crease), antecubital fossa, mid-arm and axilla; for ulnar nerve at the wrist, forearm (10 cm from the pisiform bone), at the elbow (5 cm below and above the elbow), mid-arm and axilla; the brachial plexus is measured at level C5, C6, C7.
In addition to vascularization, we also measure nerve size (cross-sectional area) and evaluate internal nerve structure.
This study aims to improve understanding of nerve involvement in Friedreich ataxia and to explore whether ultrasound could provide useful markers of disease severity."
Interested in participating?
Request Info18 year–70 year
All sexes
Observational
Nice, Alpes Maritimes, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nerve ultrasound is a widely used imaging modality in clinical practice. It allows for the measurement of nerve cross-sectional area and provides detailed visualization of internal fascicular architecture and vascularization. These features can offer indirect information about underlying nerve pathology, such as inflammation or structural damage. Reference values have been established for different segments of the median and ulnar nerves, as well as for the brachial plexus
Time frame: At the inclusion
Assessement of intraneural vascularisation by Doppler ultrasound 30 mn (composite criterion : clinical data, imaging data)
Time frame: At the inclusion
Cross sectional area ultrasound measurement in mm of median nerve at wrist, forearm (10 cm from the distal wrist crease), antecubital fossa, mid-armmedian and ulnar nerves at wrist, forearm, mid - arm and ulnar nerve at the wrist, forearm (10 cm from the pisiform bone), at the elbow (5 cm below and above the elbow), mid-arm and axilla. The brachial plexus was measured at level C5, C6, C7 30 minutes (composite criterion : clinical data, imaging data)
Time frame: At the inclusion
Ultrasound assessement of peripheral nerve echogenicity defined as hypo/hyperechogenic and internal fascicular disposition defined as preserved / loss of internal fascicular pattern (composite criterion : clinical data, imaging data)
Contact information is provided by the study sponsor or research team.
Centre Hospitalier Universitaire de Nice
Other
Friedreich Ataxia Nerve Ultrasund and Clinical Correlations
Acronym: FAUST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07721025
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Tampa, Florida, United States
View Trial DetailsNCT06628687
Brain Diseases, Central Nervous System Diseases
Morrisville, North Carolina, United States
View Trial DetailsNCT06953583
Brain Diseases, Central Nervous System Diseases
Los Angeles, California, United States
View Trial DetailsNCT06865482
Brain Diseases, Cardiomyopathies
La Jolla, California, United States
View Trial Details